Abstract:Blood pressure (BP) levels are influenced by genetic and environmental factors. Epigenome is the result of interactions between the DNA and the environment. Methylation is a naturally occurring epigenetic modification of genomic DNA and may influence BP levels. We examined the association of DNA methylation in whole blood with 24-hour and clinic BP phenotypes in 281 African Americans; fifty percent were women and fifty percent were hypertensive. Mean age of the participants was 44±7 years and mean body mass index (BMI) was 28±5 kg/m 2 . Clinic BP was obtained in duplicate from both arms and averaged using a standardized protocol as part of screening procedures for a 3-day inpatient clinical study. Blood was obtained for DNA at the time of screening visit. BP medications were discontinued for 1-week after the screening visit and prior to inpatient study. Detailed phenotyping and 24-hour BP measurements were performed during the in-patient study. DNA methylation profiles of these 281 subjects with 24-hour BP measurements were analyzed at single-base resolution with a modified reduced representation bisulfite sequencing (RRBS) method. Analysis of 38,216 DNA methylation regions, representing 1,549,368 CpG sites across the genome, identified up to 72 regions that were significantly associated with 24-hour, daytime or nighttime BPs. Considered jointly, these methylation regions explained up to 66.6% of the BP variance. Methylation regions associated with 24-hour, daytime or nighttime BPs or systolic, diastolic or mean arterial pressure or pulse pressure overlapped partially. No methylation region was significantly associated with clinic BP. Two to three methylation regions were significantly associated with 24-hour BP after adjustment for age, sex, and body mass index. These methylation regions, jointly, explained up to 16.5% of the variance of 24-hour BP, while age, sex and body mass index explained up to 11.0% of the variance. In summary, we have identified several DNA methylation regions in the whole blood that are associated with 24-hour, daytime or nighttime BPs, but not with clinic BP measured at a single point in time. DNA methylation appears to be an excellent marker for the cumulative effect of factors that influence 24-hour, daytime or nighttime BPs

Interindividual Epigenetic Variation in ABCB1 Promoter and Its Relationship with ABCB1 Expression and Function in Healthy Chinese Subjects.

Combined Influence of Genetic Polymorphism and DNA Methylation on ABCB1 Expression and Function in Healthy Chinese Males

ABCB1 Haplotype Influences the Sirolimus Dose Requirements in Chinese Renal Transplant Recipients.

Gene-Wide Characterization of Common Quantitative Trait Loci for ABCB1 Mrna Expression in Normal Liver Tissues in the Chinese Population

Influence of OATP1B1 and OATP1B3 Mutations and Glomerular Filtration Rate on Trough Serum Digoxin Concentration in the Chinese Population

Comparative and Evolutionary Pharmacogenetics of ABCB1: Complex Signatures of Positive Selection on Coding and Regulatory Regions.

The effect of ABCA1 gene DNA methylation on blood pressure levels in a Chinese hyperlipidemic population

A Functional Common Polymorphism of the ABCB1 Gene is Associated with Chronic Kidney Disease and Hypertension in Chinese

Impact Of Mdr1 Haplotypes Derived From C1236t, G2677t/A And C3435t On The Pharmacokinetics Of Single-Dose Oral Digoxin In Healthy Chinese Volunteers

Impact of individual factors on DNA methylation of drug metabolism genes: A systematic review

Abstract 035: Unique Associations of DNA Methylation with 24-Hour Blood Pressure Phenotypes in African Americans

Genetic Variation in the Proximal Promoter of ABC and SLC Superfamilies: Liver and Kidney Specific Expression and Promoter Activity Predict Variation

Impact of Individual Factors on DNA Methylation of ADME Genes: A Systematic Review

Association of ABCB1 promoter methylation with aspirin exposure, platelet function, and clinical outcomes in Chinese intracranial artery stenosis patients

Epigenetic variants of xenobiotic metabolism affect individual differences in antiepileptic drug 3,4-DCPB pharmacokinetic phenotype

Relationship Between ATP-binding Cassette Transporter 1 G596A Genetic Variation and Blood Lipids

The Risk of Clopidogrel Resistance is Associated with ABCB1 Polymorphisms but Not Promoter Methylation in a Chinese Han Population

Functional Evaluation of Genetic and Environmental Regulators of P450 Mrna Levels.

Identification of Genetic Biomarkers Associated with Pharmacokinetics and Pharmacodynamics of Apixaban in Chinese Healthy Volunteers.

Epigenetic Regulation Mechanism of ABCG2 Induced Drug-Resistant Phenotype

ABCB1 genetic polymorphisms affect opioid requirement by altering function of the intestinal P-glycoprotein